tobramycin has been researched along with Opportunistic Infections in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 12 (60.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartezaghi, M; Blasi, F; Carnovale, V; Cimino, G; Lucidi, V; Messore, B; Muscianisi, E; Porpiglia, PA; Salvatore, D | 1 |
| Alonso, T; Ancochea, J; Cisneros, C; Garcia, J; Garcia-Castillo, E; Giron, RM; Gomez-Punter, RM; Marcos, C; Valenzuela, C; Vazquez-Espinosa, E; Zamora, E | 1 |
| Iglewski, BH; Wagner, VE | 1 |
| Church, AC; Foweraker, J; Parmer, J; Sivasothy, P | 1 |
| Angyalosi, G; Kho, P; Munck, A; Ratjen, F | 1 |
| Alfonso, EC; Almeida, DR; Miller, D | 1 |
| Brokalaki, EI; Hillen, U; Sommerwerck, U; von Heinegg, EH | 1 |
| Cushing, DA; Donowitz, GR; Harman, CP; Haverstock, DC; Herrington, DA; Hurd, DD; Kowalsky, SF; Lazarus, HM; Peacock, JE; Reed, MD; Sinclair, JW; Wade, JC | 1 |
| Bodey, GP; Raad, II; Rolston, KV | 1 |
| Fishman, N; Linkin, DR | 1 |
| Huffman, GR; Morshed, S; Ries, MD | 1 |
| Darbas, H; Diego, I; Gouby, A; Jean-Pierre, H; Jeannot, JL; Jumas-Bilak, E; Marchandin, H; Teyssier, C | 1 |
| Conrad, C; Geller, DE; Konstan, MW; Noonberg, SB; Smith, J | 1 |
| Ategbo, S; Druon, D; Elian, JC; Farriaux, JP; Gottrand, F; Launay, V; Loeuille, GA; Turck, D; Vic, P | 1 |
| Doull, IJ | 1 |
| Moss, RB | 1 |
| LiPuma, JJ | 1 |
| Hasuike, T; Hirai, M; Inoue, T; Misu, K; Nakao, Y; Ohira, H; Ota, K; Tanaka, K; Yamane, T; Yasui, Y | 1 |
| Heimesaat, M; Kljucar, S; Olms, K; von Pritzbuer, E | 1 |
4 review(s) available for tobramycin and Opportunistic Infections
| Article | Year |
|---|---|
Tobramycin inhalation powder (TOBI Podhaler) for the treatment of lung infection in patients with cystic fibrosis.
Topics: Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Cystic Fibrosis; Dry Powder Inhalers; Humans; Lung; Opportunistic Infections; Prognosis; Pseudomonas aeruginosa; Pseudomonas Infections; Quality of Life; Respiratory Tract Infections; Tobramycin; Treatment Outcome | 2016 |
P. aeruginosa Biofilms in CF Infection.
Topics: Animals; Azithromycin; Biofilms; Cystic Fibrosis; DNA, Bacterial; Gene Expression Regulation, Bacterial; Humans; Immunity, Mucosal; Immunocompromised Host; Lung; Opportunistic Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing; Tobramycin | 2008 |
Mediastinal abscess after lung transplantation secondary to Burkholderia gladioli infection.
Topics: Abscess; Adult; Anti-Bacterial Agents; Burkholderia gladioli; Burkholderia Infections; Combined Modality Therapy; Cystic Fibrosis; Diagnosis, Differential; Drainage; Drug Therapy, Combination; Humans; Infusions, Intravenous; Lung Transplantation; Male; Mediastinal Diseases; Meropenem; Opportunistic Infections; Postoperative Complications; Thienamycins; Tobramycin; Tomography, X-Ray Computed | 2009 |
Recent advances in cystic fibrosis.
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Delivery of Health Care; Genetic Testing; Genetic Therapy; Genotype; Humans; Infant; Infant, Newborn; Life Expectancy; Lung Transplantation; Macrolides; Mice; Opportunistic Infections; Phenotype; Prognosis; Tobramycin | 2001 |
6 trial(s) available for tobramycin and Opportunistic Infections
| Article | Year |
|---|---|
Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Drug Administration Schedule; Female; Humans; Infant; Male; Opportunistic Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome; Young Adult | 2010 |
Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bone Marrow Transplantation; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Opportunistic Infections; Penicillins; Piperacillin; Tobramycin | 2002 |
Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety.
Topics: Administration, Inhalation; Adolescent; Adult; Anti-Bacterial Agents; Child; Cough; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Dysgeusia; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Opportunistic Infections; Powders; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Tobramycin | 2007 |
Nutritional impact of antipseudomonas intravenous antibiotic courses in cystic fibrosis.
Topics: Adolescent; Adult; Amikacin; Anthropometry; Body Composition; Ceftazidime; Child; Child, Preschool; Chronic Disease; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Nutritional Status; Opportunistic Infections; Prospective Studies; Pseudomonas Infections; Tobramycin | 1997 |
Microbiological and immunologic considerations with aerosolized drug delivery.
Topics: Aerosols; Child; Colony Count, Microbial; Cystic Fibrosis; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Long-Term Care; Microbial Sensitivity Tests; Nebulizers and Vaporizers; Opportunistic Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Stenotrophomonas maltophilia; Tobramycin | 2001 |
[Ceftazidime with and without tobramycin versus azlocillin plus tobramycin in the therapy of bronchopulmonary infections in intensive care patients].
Topics: Adult; Azlocillin; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Opportunistic Infections; Pneumonia; Random Allocation; Respiration, Artificial; Tobramycin | 1987 |
10 other study(ies) available for tobramycin and Opportunistic Infections
| Article | Year |
|---|---|
Treatment compliance in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection treated with tobramycin inhalation powder: The FREE study.
Topics: Administration, Inhalation; Adolescent; Adult; Anti-Bacterial Agents; Chronic Disease; Cystic Fibrosis; Dry Powder Inhalers; Humans; Longitudinal Studies; Medication Adherence; Opportunistic Infections; Patient Satisfaction; Pseudomonas aeruginosa; Pseudomonas Infections; Quality of Life; Tobramycin; Young Adult | 2018 |
Tsukamurella: an emerging opportunistic ocular pathogen.
Topics: Actinomycetales; Actinomycetales Infections; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Conjunctivitis, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Opportunistic Infections; Quinolines; Tobramycin | 2010 |
Ochroconis gallopavum infection in a lung transplant recipient: report of a case.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Biopsy; Bronchiolitis Obliterans; Disease Progression; Drug Administration Schedule; Enterobacter cloacae; Enterococcus; Fatal Outcome; Humans; Imipenem; Lung Transplantation; Male; Opportunistic Infections; Phaeohyphomycosis; Pyrimidines; Respiratory Tract Infections; Skin; Sputum; Tobramycin; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Summaries for patients. Treatment of fever in hospitalized patients with low white blood cell counts.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bone Marrow Transplantation; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Opportunistic Infections; Penicillins; Piperacillin; Tobramycin | 2002 |
Ciprofloxacin versus tobramycin for neutropenic fevers.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; Neutropenia; Opportunistic Infections; Penicillins; Piperacillin; Tobramycin | 2003 |
Ciprofloxacin versus tobramycin for neutropenic fevers.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; Neutropenia; Opportunistic Infections; Penicillins; Piperacillin; Tobramycin | 2003 |
Extended trochanteric osteotomy for 2-stage revision of infected total hip arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Bone Cements; Chronic Disease; Debridement; Device Removal; Female; Follow-Up Studies; Humans; Male; Middle Aged; Opportunistic Infections; Osteotomy; Postoperative Complications; Prosthesis Failure; Radiography; Reoperation; Retrospective Studies; Surgical Wound Infection; Tobramycin; Wound Healing | 2005 |
Molecular and phenotypic features for identification of the opportunistic pathogens Ochrobactrum spp.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactams; Colistin; Culture Media; DNA, Bacterial; DNA, Ribosomal; Fermentation; Gentian Violet; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Netilmicin; Ochrobactrum; Opportunistic Infections; Oxidoreductases; Phenazines; Ribotyping; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Temperature; Tobramycin; Urease | 2005 |
Administration of aerosolized antibiotics in cystic fibrosis patients.
Topics: Adolescent; Adult; Aerosols; Anti-Bacterial Agents; Child; Cystic Fibrosis; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Nebulizers and Vaporizers; Opportunistic Infections; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Tobramycin; Treatment Outcome | 2001 |
[Therapeutic effects of a combination treatment with flomoxef and tobramycin against infections complicated with hematological disorders].
Topics: Adult; Aged; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Middle Aged; Neutropenia; Opportunistic Infections; Sepsis; Tobramycin | 1992 |